Search Results - Linying Gao
- Showing 1 - 5 results of 5
-
1
-
2
-
3
Immunogenicity persistence after four intramuscular triple-dose or standard-dose hepatitis B vaccine in patients receiving methadone maintenance treatment: A 1-year follow-up study... by Xinyuan Mo, Zhaoyue Men, Linying Gao, Yizhuo Gao, Tian Yao, Yuan Liu, Yuan Yuan, Tongchuan Xue, Fuzhen Wang, Suping Wang, Keke Wang, Xiaofeng Liang, Yongliang Feng
Published in Human Vaccines & Immunotherapeutics (2025-12-01)Get full text
Article -
4
Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial by Yongliang Feng, Xiaohong Shi, Jing Shi, Linying Gao, Guangming Liu, Yanpeng Cheng, Minghu Pan, Chunxia Li, Jun Wang, Xuxia Guo, Yawei Zhang, Xiaofeng Liang, Suping Wang
Published in Expert Review of Vaccines (2017-10-01)Get full text
Article -
5
Global, regional, and national total burden related to hepatitis B and attributable risk factors in adults aged 65 years and older from 1990 to 2021 and projection to 2030 by Linying Gao, Yanfeng Ren, Yanfeng Ren, Yanfeng Ren, Yanfeng Ren, Songyue Hu, Songyue Hu, Songyue Hu, Songyue Hu, Yifan Zhang, Yifan Zhang, Yifan Zhang, Yifan Zhang, Hongjing Bai, Hongjing Bai, Hongjing Bai, Hongjing Bai, Jinbo Li, Jinbo Li, Jinbo Li, Jinbo Li, Keke Wang, Suping Wang, Suping Wang, Suping Wang, Suping Wang, Yongliang Feng, Yongliang Feng, Yongliang Feng, Yongliang Feng
Published in Frontiers in Public Health (2025-09-01)Get full text
Article
